Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

• Published in: Value in health Vol. 18; no. 2; pp. 161 - 172
• Main Authors: Ramsey, Scott D., Willke, Richard J., Glick, Henry, Reed, Shelby D., Augustovski, Federico, Jonsson, Bengt, Briggs, Andrew, Sullivan, Sean D.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2015
• Subjects: Advisory Committees; clinical trial; Cost-Benefit Analysis - methods; cost-effectiveness; economic; guidelines; Health Policy; Health Services Research - economics; Humans; Internal Medicine; Randomized Controlled Trials as Topic - economics; Randomized Controlled Trials as Topic - methods; Research Report; clinical trial; cost-effectiveness; guidelines; economic

Clinical trials evaluating medicines, medical devices, and procedures now commonly assess the economic value of these interventions. The growing number of prospective clinical/economic trials reflects both widespread interest in economic information for new technologies and the regulatory and reimbu...